Skip to content
About Prolight
Market
Partnerships
Board of Directors and Management
Clinical Advisory Board
History
Cutting-edge technology
Vision & strategy
Products
Psyros™
MicroFlex
Patents
Investors
Press releases
Financial reports
CEO comment
Financial calendar
Stock information
AGM
Shareholders
Key figures
Corporate governance
Prospectus
Issuance page – Rights issue 2025
Media
Press releases
Investor letters
Media gallery
Presentations
Articles
Contact us
About Prolight
Market
Partnerships
Board of Directors and Management
Clinical Advisory Board
History
Cutting-edge technology
Vision & strategy
Products
Psyros™
MicroFlex
Patents
Investors
Press releases
Financial reports
CEO comment
Financial calendar
Stock information
AGM
Shareholders
Key figures
Corporate governance
Prospectus
Issuance page – Rights issue 2025
Media
Press releases
Investor letters
Media gallery
Presentations
Articles
Contact us
EN
SV
Press releases
Category
All
Regulatory
Non-Regulatory
Interim
Annual
Year
All
2026
2025
2024
2023
2022
2025
2025-03-26 08:00
Prolight receives notice of allowance for MicroFlex patent
2025-03-13 08:00
The Psyros™ Cartridge Pilot Manufacturing line achieves another milestone!
2025-02-28 09:50
Prolight Diagnostics publishes year-end report 2024
Regulatory
MAR
2025-02-19 08:00
Prolight receives second Notice of Intention to Grant from European Patent Office for Psyros™ technology
2025-02-18 08:00
Prolight receives Notice of Intention to Grant for core Psyros™ patent
2024
2024-12-17 11:00
Prolight Diagnostics publishes investor letter for December 2024
2024-12-09 08:00
Prolight strengthens IP portfolio by additional patent application
2024-12-03 13:41
EMERGERS VALUE PROLIGHT DIAGNOSTICS AT 730 MSEK (0,9- 1,0 SEK PER SHARE)
2024-12-03 08:00
Prolight achieves significant milestone with arrival of first Psyros™ commercial prototype instruments
2024-11-29 08:10
The nomination committee appointed for the Annual General Meeting 2025.
Regulatory
Previous
Next